# MRgFUS Versus EBRT in Patients With Metastatic Non-spinal Bone Disease

> **NCT03404362** · NA · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 198 (actual)

## Conditions studied

- Secondary Bone Cancer
- Bone Metastases

## Interventions

- **PROCEDURE:** Bone Metastases Pain treatment

## Key facts

- **NCT ID:** NCT03404362
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2019-05
- **Final completion:** 2020-09
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03404362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03404362, "MRgFUS Versus EBRT in Patients With Metastatic Non-spinal Bone Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03404362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*